Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Dietary flavonoids have many health-promoting actions, including anticancer activity via proteasome inhibition. Bor-tezomib is a dipeptide boronate proteasome inhibitor that has activity in the treatment of multiple myeloma but is not effective in chronic lymphocytic leukemia (CLL). Although CLL cel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Liu, Feng-Ting, Agrawal, Samir G., Movasaghi, Zanyar, Wyatt, Peter B., Rehman, Ihtesham U., Gribben, John G., Newland, Adrian C., Jia, Li
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292595/
https://ncbi.nlm.nih.gov/pubmed/18633129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-04-150227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados